vs
Side-by-side financial comparison of Cigna (CI) and TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (TSM). Click either name above to swap in a different company.
Cigna is the larger business by last-quarter revenue ($68.5B vs $35.5B, roughly 1.9× TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD).
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.
Taiwan Semiconductor Manufacturing Company (TSMC) is the world's largest dedicated independent semiconductor foundry, headquartered in Hsinchu, Taiwan. It manufactures advanced logic chips on contract for fabless customers including Apple, NVIDIA, AMD, Qualcomm, and Broadcom, and leads the industry in leading-edge process nodes (3nm/5nm/7nm).
CI vs TSM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $68.5B | $35.5B |
| Net Profit | — | $17.9B |
| Gross Margin | — | 66.2% |
| Operating Margin | — | 58.0% |
| Net Margin | — | 50.5% |
| Revenue YoY | -5.5% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $111.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $68.5B | $35.5B | ||
| Q4 25 | $72.5B | $32.7B | ||
| Q3 25 | $69.7B | $30.7B | ||
| Q2 25 | $67.2B | $28.9B | ||
| Q1 25 | $65.5B | $26.0B | ||
| Q4 24 | $65.6B | $88.3B | ||
| Q3 24 | $63.7B | — | ||
| Q2 24 | $60.5B | — |
| Q1 26 | — | $17.9B | ||
| Q4 25 | $1.3B | $15.8B | ||
| Q3 25 | $2.0B | $14.0B | ||
| Q2 25 | $1.6B | $12.3B | ||
| Q1 25 | $1.4B | $11.2B | ||
| Q4 24 | $1.5B | $35.3B | ||
| Q3 24 | $825.0M | — | ||
| Q2 24 | $1.6B | — |
| Q1 26 | — | 66.2% | ||
| Q4 25 | 20.3% | 62.3% | ||
| Q3 25 | 20.4% | 59.5% | ||
| Q2 25 | 20.7% | 58.6% | ||
| Q1 25 | 26.1% | 58.8% | ||
| Q4 24 | 25.3% | 56.1% | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 26.5% | — |
| Q1 26 | — | 58.0% | ||
| Q4 25 | 3.2% | 53.9% | ||
| Q3 25 | 3.7% | 50.6% | ||
| Q2 25 | 3.4% | 49.6% | ||
| Q1 25 | 3.0% | 48.5% | ||
| Q4 24 | 3.3% | 45.7% | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 4.0% | — |
| Q1 26 | — | 50.5% | ||
| Q4 25 | 1.8% | 48.3% | ||
| Q3 25 | 2.8% | 45.7% | ||
| Q2 25 | 2.4% | 42.7% | ||
| Q1 25 | 2.2% | 43.1% | ||
| Q4 24 | 2.3% | 40.0% | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.7% | — |
| Q1 26 | — | $111.55 | ||
| Q4 25 | $4.64 | $98.45 | ||
| Q3 25 | $6.98 | $87.20 | ||
| Q2 25 | $5.71 | $76.80 | ||
| Q1 25 | $4.85 | $69.70 | ||
| Q4 24 | $5.01 | $1.36 | ||
| Q3 24 | $2.63 | — | ||
| Q2 24 | $5.45 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CI
| Pharmacy revenues | $54.0B | 79% |
| Premiums | $9.8B | 14% |
| Fees and other revenues | $4.4B | 6% |
TSM
Segment breakdown not available.
